Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

[Correction of complement system failure in patients with chronic prostatitis].

Teodorovich OV, Shatokhin MN, Mykolaenko TV, Konoplia AI, Krasnov AV, Mavrin MIu, Meshanin NV.

Urologiia. 2011 Jul-Aug;(4):29-32. Russian.

PMID:
22066238
[PubMed - indexed for MEDLINE]
2.

[Correction of local immunometabolic disturbances combined with chronic prostatitis in prostatic adenoma].

Teodorovich OV, Shatokhin MN, Mal'tsov VN, Konoplia AI, Loktiononv AL, Krasnov AV.

Urologiia. 2010 Sep-Oct;(5):22-6. Russian.

PMID:
21254636
[PubMed - indexed for MEDLINE]
3.

[Efficacy of magnetolaser therapy of patients with an inflammatory form of chronic abacterial prostatitis].

Kogan MI, Shangichev AV, Belousov II.

Urologiia. 2010 Mar-Apr;(2):42-4. Russian.

PMID:
20973140
[PubMed - indexed for MEDLINE]
4.

[Efficiency of chronic prostatitis treatment with the use of the progam-apparatus complex KAP-ELM-01 "Andro-Gin"].

Usov OE, Sokolov VV.

Voen Med Zh. 2003;324(4):48-9. Russian. No abstract available.

PMID:
12825367
[PubMed - indexed for MEDLINE]
5.

Involvement of complement in psoriasis and atopic dermatitis--measurement of C3a and C5a, C3, C4 and C1 inactivator.

Kapp A, Wokalek H, Schöpf E.

Arch Dermatol Res. 1985;277(5):359-61.

PMID:
3875319
[PubMed - indexed for MEDLINE]
6.

[Validity of using physical therapy in combined treatment of chronic prostatitis].

Razumov SV, Egorov AA.

Urologiia. 2005 Mar-Apr;(2):42-6. Russian.

PMID:
15989027
[PubMed - indexed for MEDLINE]
7.

[Comparative assessment of conservative treatment of chronic prostatitis with application of complex unit andro-gin].

Golubchikova VA, Alekseev MIa, Sitnikov NV, Kochetov AG, Podgornyĭ VF.

Urologiia. 2000 Jan-Feb;(1):20-4. Russian.

PMID:
16856455
[PubMed - indexed for MEDLINE]
8.

[Psychophysiological characteristics of patients with chronic prostatitis].

Kochetov AG, Golubchikov VA, Ivanov AO, Sitnikov NV, Groshilin SM, Glinskiĭ VM.

Urologiia. 2003 Sep-Oct;(5):26-31. Russian.

PMID:
14658268
[PubMed - indexed for MEDLINE]
9.

Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies.

Klos A, Ihrig V, Messner M, Grabbe J, Bitter-Suermann D.

J Immunol Methods. 1988 Jul 22;111(2):241-52.

PMID:
3260926
[PubMed - indexed for MEDLINE]
10.

[Effects of immunocorrective therapy on immunological indices in patients with chronic bacterial prostatitis].

Repin EV, Dolgikh VT, Dolgikh TN, Ershov AV, Repina TV.

Urologiia. 2011 Nov-Dec;(6):50-4. Russian.

PMID:
22448482
[PubMed - indexed for MEDLINE]
11.

Involvement of complement in atopic dermatitis.

Kapp A, Schöpf E.

Acta Derm Venereol Suppl (Stockh). 1985;114:152-4.

PMID:
3923750
[PubMed - indexed for MEDLINE]
12.

[New aspects of efficacy of using apparatus-programming complex "andro-gin" in the treatment of chronic prostatitis].

Pereverzev AS, Chepenko AV.

Urologiia. 2006 Sep-Oct;(5):51-4, 59. Russian.

PMID:
17444153
[PubMed - indexed for MEDLINE]
13.

Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.

Strunk RC, Eidlen DM, Mason RJ.

J Clin Invest. 1988 May;81(5):1419-26.

PMID:
2966814
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

[Biologically controlled magnetolaser therapy of chronic abacterial prostatitis].

Shangichev AV.

Vopr Kurortol Fizioter Lech Fiz Kult. 2009 May-Jun;(3):37-40. Russian.

PMID:
19637838
[PubMed - indexed for MEDLINE]
15.

Generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for the adult respiratory distress syndrome.

Zilow G, Joka T, Obertacke U, Rother U, Kirschfink M.

Crit Care Med. 1992 Apr;20(4):468-73.

PMID:
1559358
[PubMed - indexed for MEDLINE]
16.

Anaphylatoxin generation in multisystem organ failure.

Heideman M, Hugli TE.

J Trauma. 1984 Dec;24(12):1038-43.

PMID:
6334754
[PubMed - indexed for MEDLINE]
17.

Complement activation in type 1 human diabetes.

Sundsmo JS, Papin RA, Wood L, Hirani S, Waldeck N, Buckingham B, Kershnar A, Ascher M, Charles MA.

Clin Immunol Immunopathol. 1985 May;35(2):211-25.

PMID:
3907907
[PubMed - indexed for MEDLINE]
18.

Chronological changes in the complement system in sepsis.

Nakae H, Endo S, Inada K, Yoshida M.

Surg Today. 1996;26(4):225-9.

PMID:
8727941
[PubMed - indexed for MEDLINE]
19.

Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.

Belmont HM, Hopkins P, Edelson HS, Kaplan HB, Ludewig R, Weissmann G, Abramson S.

Arthritis Rheum. 1986 Sep;29(9):1085-9.

PMID:
3489467
[PubMed - indexed for MEDLINE]
20.

Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome.

Stöve S, Welte T, Wagner TO, Kola A, Klos A, Bautsch W, Köhl J.

Clin Diagn Lab Immunol. 1996 Mar;3(2):175-83.

PMID:
8991632
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk